Physician profile
Martin S Trott
NPI 1245339456
$97,371.51
in general payments reported to CMS, 2019-2025
10 companies · $19K in 2025
The $19K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,789 · 2020: $1,326 · 2021: $2,839 · 2022: $7,465 · 2023: $51K · 2024: $12K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Honoraria: $14K · Travel and Lodging: $12K · Food and Beverage: $3,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,536.25 |
| Honoraria | $13,800.00 |
| Travel and Lodging | $11,902.92 |
| Food and Beverage | $3,713.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $89,854.08 | 2020-2025 | Inspire |
| Intersect Ent, INC. | $2,765.37 | 2019 | |
| Medtronic, INC. | $1,841.92 | 2023 | Stealthstation S8 Platform, Fusion, Cd Horizon Spinal System |
| Stryker Corporation | $1,467.05 | 2023 | Scopis Ent |
| Medical Device Business Services, INC. | $884.30 | 2023 | |
| Acclarent, INC | $376.00 | 2023 | Relieva Spinplus, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $94.57 | 2022-2024 | Dupixent |
| Optinose US, INC. | $46.68 | 2022 | |
| Genzyme Corporation | $23.64 | 2019 | |
| Karl Storz Endoscopy-America | $17.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Trott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.